T6943 |
Picropodophyllin
|
477-47-4
|
99.41%
|
|
Picropodophyllin (Picropodophyllin (PPP)) (PPP) is a specific IGF-1R inhibitor (IC50: 1 nM). Picropodophyllin specifically inhibits the activity and downregulate...
|
T2693 |
AG1024
|
65678-07-1
|
99.37%
|
|
AG1024 (Tyrphostin) suppresses IGF-1R autophosphorylation(IC50=7 μM), and is less potent for IR(IC50=57 μM).
|
T8221 |
Insulin (human)
|
11061-68-0
|
99.34%
|
|
Insulin (human) is a peptide hormone that promotes glycogen synthesis and regulates glucose levels in the blood. Insulin (human) has hypoglycemic activity and is...
|
T6057 |
URMC-099
|
1229582-33-5
|
99.32%
|
|
URMC-099 is an orally bioavailable, brain penetrant MLK inhibitor (IC50: 19/42/14/150 nM, for MLK1/MLK2/MLK3/DLK), and also inhibits LRRK2 activity (IC50: 11 nM)...
|
T24398 |
Lenaldekar
|
418800-15-4
|
99.25%
|
|
Lenaldekar (LDK) inhibits T-cell expansion and autoimmune encephalomyelitis. Lenaldekar causes dephosphorylation of members of the PI3 kinase/AKT/mTOR pathway an...
|
T6419 |
BMS-536924
|
468740-43-4
|
99.19%
|
|
BMS-536924 (BMS 536924) is an ATP-competitive IGF-1R/IR inhibitor with IC50 of 100 nM/73 nM, modest activity for Mek, Fak, and Lck with very little activity for ...
|
T6932 |
PD168393
|
194423-15-9
|
99.13%
|
|
PD168393 is an irreversible EGFR inhibitor (IC50: 0.70 nM), irreversibly alkylate Cys-773; inactive against PKC, FGFR, PDGFR, and insulin.
|
T2085 |
PQ401
|
196868-63-0
|
99.13%
|
|
PQ401 (IGF-1R Inhibitor II) suppresses autophosphorylation of IGF-1R domain(IC50<1 μM).
|
T1967 |
AZD-3463
|
1356962-20-3
|
99.13%
|
|
AZD-3463 (ALK/IGF1R inhibitor) , an orally bioavailable ALK inhibitor (Ki: 0.75 nM), can inhibit IGF1R with equivalent potency.
|
T21761 |
HNMPA
|
132541-52-7
|
99.11%
|
|
HNMPA is a membrane impermeable inhibitor of insulin receptor tyrosine kinase. HNMPA inhibits tyrosine and serine autophosphorylation by the human insulin recep...
|
T68405 |
KW-2450 free base
|
904899-25-8
|
99.11%
|
|
KW-2450 free base is a multiple inhibitor of IGF-1R/IR and tyrosine kinases with antitumor activity.KW-2450 free base shows modest growth inhibitory activity and...
|
T6017 |
Linsitinib
|
867160-71-2
|
98.98%
|
|
OSI-906 (Linsitinib (OSI-906)) is an orally bioavailable small molecule inhibitor of the insulin-like growth factor 1 receptor (IGF-1R) with potential antineopla...
|
T17267 |
XL228
|
898280-07-4
|
98.92%
|
|
XL228 is an inhibitor of multi-targeted tyrosine kinase (IC50s: 5, 3.1, 1.6, 6.1, 2 nM for Bcr-Abl, Aurora A, IGF-1R, Src, and Lyn, respectively).
|
T6003 |
GSK1904529A
|
1089283-49-7
|
98.89%
|
|
GSK1904529A (GSK 4529) is a specific inhibitor of IGF-1R (IC50=27 nM) and IR(IC50=25 nM) .
|
T2755 |
Rhoifolin
|
17306-46-6
|
98.87%
|
|
Rhoifolin (Apigenin 7-O-neohesperidoside) is extracted from Turpinia arguya Seem dried leaves.
|
T2349 |
BMS-754807
|
1001350-96-4
|
98.86%
|
|
Dual IGF-1R/InsR Inhibitor BMS-754807 is an oral small molecule inhibitor of insulin-like growth factor 1 receptor (IGF-1R) and insulin receptor (InsR) tyrosine ...
|
TP2018L |
GIP (human) acetate
|
TP2018L
|
98.65%
|
|
GIP (human) acetate is a stimulator of glucose-dependent insulin secretion and a weak inhibitor of gastric acid secretion. GIP (human) acetate plays a vital role...
|
T10285 |
ALK inhibitor 1
|
761436-81-1
|
98.55%
|
|
ALK inhibitor 1 is a selective ALK kinase inhibitor.
|
T37588L |
GIP (1-30) amide, porcine acetate
|
|
98.50%
|
|
GIP (1-30) amide, porcine acetate is an agonist of fully glucose-dependent insulinotropic polypeptide (GIP) receptor. GIP (1-30) amide, porcine acetate can weakl...
|
T2642 |
PD173074
|
219580-11-7
|
98.15%
|
|
PD173074 is an effective FGFR1 inhibitor (IC50: 25 nM) and also inhibits VEGFR2 (IC50: 100-200 nM) in cell-free assays. The selectivity is higher ~1000-fold for ...
|